NASDAQ:AGPU

Predictive Oncology Stock Earnings Reports

etoro logo Buy AGPU
*Your capital is at risk
$7.73
-0.440 (-5.39%)
At Close: Jun 05, 2026

Predictive Oncology Earnings Calls

Mar 31, 2026
Release date May 15, 2026
EPS estimate -
EPS actual -$0.360
Revenue estimate -
Revenue actual 35.311K
Dec 31, 2025
$1.15 (12,645.56%)
Release date Mar 31, 2026
EPS estimate $0.0090
EPS actual $1.15
EPS Surprise 12,645.56%
Revenue estimate 5M
Revenue actual 8.674K
Revenue Surprise -99.83%
Sep 30, 2025
-$4.52 (-234.81%)
Release date Nov 14, 2025
EPS estimate -$1.35
EPS actual -$4.52
EPS Surprise -234.81%
Revenue estimate 1.5M
Revenue actual 3.618K
Revenue Surprise -99.76%
Jun 30, 2025
-$3.30 (-144.44%)
Release date Aug 13, 2025
EPS estimate -$1.35
EPS actual -$3.30
EPS Surprise -144.44%
Revenue estimate 1.5M
Revenue actual 2.682K
Revenue Surprise -99.82%

Last 4 Quarters for Predictive Oncology

Below you can see how AGPU performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Jun 30, 2025 Missed
Release date Aug 13, 2025
Price on release $
EPS estimate -$1.35
EPS actual -$3.30
EPS surprise -144.44%
Date Price
Nov 13, 2025 $6.50
Nov 14, 2025 $6.48
Nov 17, 2025 $6.08
Nov 18, 2025 $6.03
4 days before -100.00%
4 days after 0%
On release day 0%
Change in period -7.23%
Sep 30, 2025 Missed
Release date Nov 14, 2025
Price on release $6.48
EPS estimate -$1.35
EPS actual -$4.52
EPS surprise -234.81%
Date Price
Nov 13, 2025 $6.50
Nov 14, 2025 $6.48
Nov 17, 2025 $6.08
Nov 18, 2025 $6.03
Nov 19, 2025 $6.22
Nov 20, 2025 $6.05
4 days before -0.308%
4 days after -6.64%
On release day -6.17%
Change in period -6.92%
Dec 31, 2025 Beat
Release date Mar 31, 2026
Price on release $1.62
EPS estimate $0.0090
EPS actual $1.15
EPS surprise 12,645.56%
Date Price
Mar 25, 2026 $1.61
Mar 26, 2026 $1.48
Mar 27, 2026 $1.55
Mar 30, 2026 $1.47
Mar 31, 2026 $1.62
Apr 01, 2026 $3.56
Apr 02, 2026 $4.07
Apr 06, 2026 $4.25
Apr 07, 2026 $4.76
4 days before 0.621%
4 days after 193.83%
On release day 119.75%
Change in period 195.65%
Mar 31, 2026
Release date May 15, 2026
Price on release $5.85
EPS estimate -
EPS actual -$0.360
Date Price
May 11, 2026 $6.66
May 12, 2026 $6.66
May 13, 2026 $6.48
May 14, 2026 $5.60
May 15, 2026 $5.85
May 18, 2026 $4.68
May 19, 2026 $4.76
May 20, 2026 $5.13
May 21, 2026 $5.70
4 days before -12.16%
4 days after -2.56%
On release day -20.00%
Change in period -14.41%

Predictive Oncology Earnings Call Transcript Summary of Q1 2026

Axe Compute (AGPU) presented Q1 2026 results and an updated go‑forward strategy focused on building and owning GPU clusters deployed inside third‑party data centers. The company operates two customer tracks: (1) immediate access inventory for rapid short‑term needs, and (2) Axe Build long‑term dedicated clusters (3–5 year contracts) that Axe finances, installs, and retains as balance‑sheet assets for redeployment. The company closed a landmark 36‑month, $260 million contract for 2,304 NVIDIA B300s (4.8 MW) in a U.S. Tier 3 data center with targeted deployment in Q3 2026; when live this cluster will drive approximately $21 million of revenue per quarter. Management reports an advanced pipeline of ~45 qualified prospects representing >36,000 GPUs and over $4.3 billion of potential contract value, with a majority of deals trending to 36–60 month terms; the CEO expressed confidence in closing roughly $1 billion of transactions this year. Q1 financials reflect the transitional nature of the business: total revenue was $35k (legacy Drug Discovery declining), net loss $7.7M (largely noncash), cash and equivalents $6.9M, total assets $45.2M, and total equity $40.3M. The CFO emphasized that $4.3M of the Q1 loss was a GAAP mark‑to‑market loss on Aethir token holdings (fair value accounting), which were $20.2M at quarter‑end, and that $15.4M of additional locked tokens are contractual receivables vesting through Dec 2028. Management expects the Axe Build model to generate recurring cash flow and to build owned AI infrastructure assets on the balance sheet that can be redeployed and amortized over shorter equipment lives (3–5 years).

Predictive Oncology Earnings History

Earnings Calendar

FAQ

When is the earnings report for AGPU?
Predictive Oncology Inc. (AGPU) has scheduled its earnings report for Aug 06, 2026 after the markets close.

What is the AGPU price-to-earnings (P/E) ratio?
AGPU P/E ratio as of Jun 05, 2026 (TTM) is -0.687.

What is the AGPU EPS forecast?
The forecasted EPS (Earnings Per Share) for Predictive Oncology Inc. (AGPU) for the first fiscal quarter 2026 is $.

What are Predictive Oncology Inc.'s retained earnings?
On its balance sheet, Predictive Oncology Inc. reported retained earnings of $35.31 thousand for the latest quarter ending Mar 31, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
FIZZ
$34.11
7.04% May 01
W
WCLD
$27.34
17.78% Apr 29
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE